Elastomeric Infusion Pump Market
Elastomeric Infusion Pump Market Study by Continuous and Variable Rate Pumps for Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, and Others from 2024 to 2034
Analysis of Elastomeric Infusion Pump Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
FREE CustomizationElastomeric Infusion Pump Market Outlook (2024 to 2034)
The global elastomeric infusion pump market size is expected to be worth US$ 1,243.8 million in 2024. The market is anticipated to reach US$ 2,649.5 million by 2034. The adoption of elastomeric infusion pump is likely to rise at a CAGR of 7.9% through 2034.
Key Market Growth Drivers
- The increasing incidence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, fuels the demand for elastomeric infusion pumps.
- There is a growing trend towards home-based healthcare solutions, driven by the preference for comfort and cost-effectiveness.
- The rising number of surgical procedures, including post-operative pain management and ambulatory care, amplifies the demand for elastomeric infusion pumps. These devices offer a reliable method for delivering controlled and continuous medication, supporting effective recovery.
- Elastomeric infusion pumps find increased applications in pediatric care, offering a safe and efficient means of administering medications to children. The demand for pediatric-friendly infusion solutions further contributes to market expansion.
The growing acceptance and adoption of home infusion therapy contributes significantly to the elastomeric infusion pump market. These pumps facilitate the administration of intravenous medications in a home setting, providing convenience and reducing the burden on healthcare facilities.
The increasing prevalence of ambulatory care centers and outpatient settings enhances the demand for elastomeric infusion pumps. These centers utilize these pumps for efficient and controlled drug delivery during short-term treatments, surgeries, or diagnostic procedures.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 1,243.8 million |
| Forecasted Market Value (2034F) | US$ 2,649.5 million |
| Global Market Growth Rate (2024 to 2034) | 7.9%CAGR |
| Continuous Rate Elastomeric Pumps Segment Share (2024) | 68.1% |
| Hospitals Segment Share (2024) | 39.7% |
| North America Market Share (2024) | 33.9% |
| East Asia Market Share (2024) | 30.2% |
| Key Companies Profiled | B. Braun SE; Coloplast Group; Shanghai Kindly Medical Instrument Co., Ltd.; SOOIL Developments Co., Ltd.; Micrel Medical Devices SA; Daiken Iki Corporation; Leventon, S.A.U.; Avanos Medical, Inc. |
Which Trends Influence the Sales of Elastomeric Infusion Pump through 2034?
"Healthcare Providers Embrace for a Shift Towards Disposable Systems "
Meeting the demand for more convenient and cost-effective solutions, there is a noticeable trend in the elastomeric infusion pump industry toward disposable systems. These pumps address a critical need by eliminating the requirements for intricate cleaning and sterilization processes, making them particularly advantageous for short-term therapies.
The disposable nature of these systems not only streamlines the treatment process but also minimizes the risk of contamination, enhancing patient safety. As healthcare providers and patients seek more efficient and user-friendly options, the shift towards disposable elastomeric infusion pumps reflects a commitment to simplifying therapeutic procedures and improving overall treatment experiences.
This trend underscores the industry's responsiveness to the evolving preferences of both healthcare professionals and patients, aligning with the broader goal of enhancing healthcare delivery.
"Focus on Patient Comfort and Mobility Becomes a Rising Trend"
Recognizing the significance of patient experience, manufacturers in the elastomeric infusion pump industry are placing increased focus on patient comfort and mobility in pump design. The development of lighter and more compact pump models with ergonomic features represents a concerted effort to enhance the overall treatment experience.
These design innovations contribute to increased patient comfort during the infusion process and enable greater mobility, allowing individuals to maintain an active lifestyle while undergoing treatment. Manufacturers are responding to the evolving expectations of patients and healthcare providers by prioritizing features that enhance patient well-being and convenience.
This focus on patient-centric design underscores the industry's commitment to fostering positive healthcare experiences and aligning with the broader trend toward patient-centered care in the medical field.
Which Factors Present Hurdles in the Elastomeric Infusion Pump Market Expansion?
"Regulatory Compliance, Limited Reimbursement Policies, and Logistical Complexities Pose a Threat to Market Expansion"
The stringent regulatory requirements governing medical devices pose a significant challenge to market players. Ensuring compliance with varying standards and regulations across different regions demands substantial resources and expertise. Navigating the intricate regulatory landscape is crucial for market participants to gain approvals and certifications, influencing their market access and competitiveness.
The elastomeric infusion pump industry encounters challenges related to reimbursement policies. The limited coverage and reimbursement for certain therapies using elastomeric pumps can hinder market expansion. Collaborative efforts between industry stakeholders and healthcare policymakers are essential to address this hurdle and create a more conducive reimbursement environment.
The logistics associated with the distribution and supply chain of elastomeric infusion pumps can pose challenges. Ensuring timely and efficient delivery, especially in geographically diverse markets, requires robust logistical strategies. Overcoming these complexities is vital to maintaining a seamless and reliable supply of elastomeric infusion pumps to healthcare facilities and end-users.
Country-wise Insights
North America's elastomeric infusion pump industry is likely to be worth US$ 422 million in 2024, holding a share of 33.9% in the global market. Also, East Asia's elastomeric infusion pump industry is projected to be worth US$ 375 million in 2024, with a share of 30.2%.
Growth Outlook for Countries in North America
| Country | Market Share in 2024 |
|---|---|
| United States | 87.3% |
| Canada | 9.7% |
| Mexico | 3.0% |
Why the United States Hold the Dominance in the Elastomeric Infusion Pump Market?
"The United States Elastomeric Infusion Pump Industry Dominance with a Share of 87.3% in 2024"
The United States elastomeric infusion pump industry is predicted to garner an 87.3% share in 2024. The United States boasts a well-developed healthcare system with a high prevalence of specialized care facilities. This creates a significant demand for elastomeric pumps for pain management, chemotherapy delivery, and other critical applications.
Leading American medical device companies invest heavily in research and development, continuously pushing the boundaries of elastomeric pump technology. This innovation leads to advanced features, improved functionality, and wider adoption in clinical settings. The United States Food and Drug Administration (FDA) has a well-established regulatory framework for medical devices, including elastomeric pumps. This clear and predictable regulatory pathway encourages manufacturers to bring new products to market quickly.
The United States healthcare system, with a mix of private insurance and government programs like Medicare, provides favorable reimbursement for elastomeric pumps. This financial support makes these pumps readily accessible to patients and healthcare providers. The United States faces a growing burden of chronic diseases like cancer and pain management, which often require the use of elastomeric pumps. This increasing demand further fuels elastomeric infusion pump market growth.
Growth Outlook for Countries in East Asia
| Country | Market Share in 2024 |
|---|---|
| China | 73.7% |
| Japan | 15.4% |
| Korea | 10.9% |
Which Country in East Asia Holds the Dominant Share in the Elastomeric Infusion Pump Industry?
"China to Hold a 73.7% Share in the Elastomeric Infusion Pump Industry"
China is set to claim an impressive 73.7% share of the elastomeric infusion pump industry in 2024. China's healthcare sector is experiencing rapid expansion, with increasing investments in hospitals and medical infrastructure. This creates fertile ground for the adoption of advanced medical devices like elastomeric pumps for pain management, chemotherapy delivery, and other vital applications.
Similar to other countries, China faces a rapidly aging population, leading to a higher prevalence of chronic diseases and a greater need for elastomeric pumps for pain management and other long-term care needs. Recognizing the importance of healthcare, the Chinese government is actively promoting domestic innovation and the production of medical devices, including elastomeric pumps. This support provides financial incentives and regulatory ease, fostering a thriving domestic market.
China's manufacturing prowess is extending to the medical device sector. Local companies are developing and producing high-quality elastomeric pumps at competitive prices, making them increasingly attractive to healthcare providers and patients alike. With healthcare costs rising globally, China's emphasis on affordability is playing a crucial role in the market's growth. The availability of domestically produced, cost-effective elastomeric pumps makes them accessible to a wider segment of the population, furthering driving demand.
Category-wise Insights
By product, the continuous rate elastomeric pump segment is projected to hold a 68.1% share in 2024. Simultaneously, the hospitals end user segment is anticipated to secure a 39.7% share in 2024.
Why is Demand for Continuous Rate Elastomeric Pumps Rising Rapidly?
"Demand for Continuous Rate Elastomeric Pumps to Rise at CAGR of 8.5% through 2034"
The continuous rate elastomeric pump product segment is anticipated to witness a remarkable CAGR of 8.5% through 2034. Unlike traditional gravity-fed pumps, continuous rate pumps accurately deliver medication at a consistent flow rate, even over extended periods.
This precision minimizes the risk of errors and ensures optimal treatment efficacy, particularly for critical medications. These pumps handle a wide range of medications and viscosities, making them suitable for diverse treatments. Their compact, portable design allows for outpatient use, empowering patients to manage their care at home, and improving flexibility and quality of life.
Advanced pumps come equipped with built-in alarms and safety mechanisms to prevent accidental overdosing or underdosing. This enhances patient safety and reduces caregiver anxiety, particularly in homecare settings. While initial costs for continuous rate pumps may be higher, their long-term benefits outweigh the expense. Reduced medication waste, improved treatment outcomes, and decreased hospital readmissions contribute to overall cost savings for healthcare providers.
Which End User Segment Dominates the Elastomeric Infusion Pump Industry in 2024?
"Adoption of Elastomeric Infusion Pump in Hospitals to Rise at a CAGR of 7.6% through 2034"
The hospitals emerge as the dominant end user segment with a share of 39.7% in 2024. Hospitals cater to a wide range of acute and critical conditions, often requiring continuous medication delivery for pain management, chemotherapy, and other critical applications. This high demand fuels the adoption of elastomeric pumps in these settings.
Hospitals often manage complex treatment regimens requiring precise and reliable medication delivery. Continuous rate pumps, with their advanced features and accuracy, prove invaluable in ensuring optimal outcomes for patients with intricate care needs. Hospitals must take a step ahead in adopting new technologies, and advancements in elastomeric pumps, such as smart features and remote monitoring capabilities, further incentivize their integration into hospital workflows.
Competitive Landscape
The competition in the elastomeric infusion pump market is drawing a diverse array of contenders seeking a share in its expanding domain. Established Players encompass healthcare giants with extensive distribution networks, medical device specialists utilizing advanced technology, and influential entities like hospital networks and group purchasing organizations.
On the other hand, emerging players consist of innovative startups, direct-to-consumer brands bypassing traditional channels, and manufacturers in developing economies capitalizing on lower production costs.
To navigate this market, companies employ various strategies. Innovation is paramount, driving continuous research and development to create pumps with cutting-edge features, improved functionality, and enhanced user experience.
Strategic partnerships are pursued, whether with healthcare providers, research institutions, or complementary technology companies, to unlock new market opportunities and accelerate growth. Additionally, a focus on affordability, catering to budget-conscious healthcare institutions or developing regions, and an emphasis on customer service, including excellent support, technical training, and after-sales service, are identified as key competitive edges in this market.
Recent Developments :
- B. Braun introduced the SpacePump+ Pro Infusion System, featuring integrated smart functionalities like wireless medication verification and remote monitoring capabilities.
- Coloplast launched the Confi-Lock Duo elastomeric pump, designed for dual medication delivery with enhanced safety features and intuitive usability.
- Micrel Medical Devices launched the iQ-Infusion smart elastomeric pump with advanced data tracking and reporting capabilities, offering improved care insights for healthcare providers.
- A+vanos Medical announced a partnership with a leading home healthcare provider to distribute its elastomeric pumps for pain management, aiming to expand into the homecare market.
Segmentation of Elastomeric Infusion Pump Market Research
-
By Product :
- Continuous Rate Elastomeric Pumps
- Variable Rate Elastomeric Pumps
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Clinics
- Others
-
By Treatment :
- Pain Management
- Antiboitic/Antiviral
- Chemotherapy
- Others
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
- 5.1. Continuous Rate Elastomeric Pumps
- 5.2. Variable Rate Elastomeric Pumps
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment
- 6.1. Pain Management
- 6.2. Antibiotic/Antiviral
- 6.3. Chemotherapy
- 6.4. Others
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 7.1. Hospitals
- 7.2. Ambulatory Surgical Centres
- 7.3. Home Care Settings
- 7.4. Clinics
- 7.5. Others
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Western Europe
- 8.4. Eastern Europe
- 8.5. South Asia and Pacific
- 8.6. East Asia
- 8.7. Middle East and Africa
- 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 16. Key Countries Market Analysis
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Baxter International, Inc.
- 18.2. Fresenius Kabi AG
- 18.3. B. Braun Melsungen AG
- 18.4. Ambu A/S
- 18.5. Leventon, S.A.U.
- 18.6. Nipro Corporation
- 18.7. Terumo Corporation
- 18.8. Avanos Medical, Inc.
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 02: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 03: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 04: Global Market Volume (Units) Forecast by Product, 2019 to 2034
Table 05: Global Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 06: Global Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 07: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 08: Global Market Volume (Units) Forecast by End User, 2019 to 2034
Table 09: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 13: North America Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 15: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 19: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 20: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 21: Latin America Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 22: Latin America Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 23: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 24: Latin America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 25: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 28: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 29: Western Europe Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 30: Western Europe Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 31: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 32: Western Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 33: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 35: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 36: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 37: Eastern Europe Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 38: Eastern Europe Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 39: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 40: Eastern Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 43: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 44: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034
Table 45: South Asia and Pacific Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 46: South Asia and Pacific Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 47: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 48: South Asia and Pacific Market Volume (Units) Forecast by End User, 2019 to 2034
Table 49: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 51: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 52: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034
Table 53: East Asia Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 54: East Asia Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 55: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 56: East Asia Market Volume (Units) Forecast by End User, 2019 to 2034
Table 57: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 59: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 60: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034
Table 61: Middle East and Africa Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 62: Middle East and Africa Market Volume (Units) Forecast by Treatment, 2019 to 2034
Table 63: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 64: Middle East and Africa Market Volume (Units) Forecast by End User, 2019 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Million) by Product, 2024 to 2034
Figure 02: Global Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 03: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 04: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 05: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 06: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 07: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 08: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 09: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 10: Global Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 13: Global Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 14: Global Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 17: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 18: Global Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 21: Global Market Attractiveness by Product, 2024 to 2034
Figure 22: Global Market Attractiveness by Treatment, 2024 to 2034
Figure 23: Global Market Attractiveness by End User, 2024 to 2034
Figure 24: Global Market Attractiveness by Region, 2024 to 2034
Figure 25: North America Market Value (US$ Million) by Product, 2024 to 2034
Figure 26: North America Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 27: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 28: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 29: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 33: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 34: North America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 37: North America Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 38: North America Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 39: North America Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 40: North America Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 41: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 42: North America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 43: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 44: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 45: North America Market Attractiveness by Product, 2024 to 2034
Figure 46: North America Market Attractiveness by Treatment, 2024 to 2034
Figure 47: North America Market Attractiveness by End User, 2024 to 2034
Figure 48: North America Market Attractiveness by Country, 2024 to 2034
Figure 49: Latin America Market Value (US$ Million) by Product, 2024 to 2034
Figure 50: Latin America Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 52: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 57: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 58: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 61: Latin America Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 62: Latin America Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 66: Latin America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 67: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 69: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 70: Latin America Market Attractiveness by Treatment, 2024 to 2034
Figure 71: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 73: Western Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 75: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 77: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 82: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 85: Western Europe Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 86: Western Europe Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 89: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 90: Western Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 93: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 94: Western Europe Market Attractiveness by Treatment, 2024 to 2034
Figure 95: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 97: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 98: Eastern Europe Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 99: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 100: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 106: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 110: Eastern Europe Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 113: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 114: Eastern Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 117: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 118: Eastern Europe Market Attractiveness by Treatment, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034
Figure 122: South Asia and Pacific Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 123: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 124: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 133: South Asia and Pacific Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 138: South Asia and Pacific Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 141: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 142: South Asia and Pacific Market Attractiveness by Treatment, 2024 to 2034
Figure 143: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 145: East Asia Market Value (US$ Million) by Product, 2024 to 2034
Figure 146: East Asia Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 147: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 148: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 149: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 153: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 154: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 155: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 157: East Asia Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 158: East Asia Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 159: East Asia Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 161: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 162: East Asia Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 165: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 166: East Asia Market Attractiveness by Treatment, 2024 to 2034
Figure 167: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 169: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034
Figure 170: Middle East and Africa Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 171: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 172: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 173: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 178: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 182: Middle East and Africa Market Volume (Units) Analysis by Treatment, 2019 to 2034
Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 185: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 186: Middle East and Africa Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 189: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 190: Middle East and Africa Market Attractiveness by Treatment, 2024 to 2034
Figure 191: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
- FAQs -
What was the value of the elastomeric infusion pump market in 2019?
The global elastomeric infusion pump market was worth US$ 841.9 million in 2019.
What is the sales outlook for elastomeric infusion pump in 2024?
The sales outlook for elastomeric infusion pump is likely to be valued at US$ 1,243.8 million in 2024.
What is the demand forecast for elastomeric infusion pump for the decade?
Demand for elastomeric infusion pump is projected to reach a market value of US$ 2,649.5 million by 2034.
What is the adoption growth projection for elastomeric infusion pump?
Adoption of elastomeric infusion pump is projected to rise at a CAGR of 7.9% through 2034.
At what rate is the market in the United States predicted to grow?
The United States elastomeric infusion pump industry is forecasted to expand at a CAGR of 7.7% through 2034.
Elastomeric Infusion Pump Market